E Fund Management Co., Ltd. - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$204
-29.9%
66,978
-24.4%
0.02%
-30.4%
Q2 2023$291
-0.7%
88,590
-3.9%
0.02%
+9.5%
Q1 2023$293
-25.1%
92,143
+63.3%
0.02%
-36.4%
Q4 2022$391
-99.9%
56,432
-15.4%
0.03%
-15.4%
Q3 2022$422,000
+77.3%
66,715
+35.8%
0.04%
+387.5%
Q1 2022$238,000
+23.3%
49,119
+153.8%
0.01%
+14.3%
Q4 2021$193,00019,3540.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 4,282,827$13,019,7941.84%
Birchview Capital, LP 455,200$1,383,8081.18%
PFM Health Sciences, LP 6,040,934$18,364,4390.86%
Lion Point Capital, LP 531,256$1,615,0180.72%
Endurant Capital Management LP 251,785$765,4260.69%
Bleichroeder LP 900,000$2,736,0000.67%
Connacht Asset Management LP 31,634$96,1670.57%
Granahan Investment Management 5,137,778$15,618,8450.56%
Frazier Life Sciences Management, L.P. 1,709,907$5,198,1170.34%
Contrarius Investment Management Ltd 1,308,002$3,9760.22%
View complete list of BLUEBIRD BIO INC shareholders